MAPT and Alzheimer disease: Notably, plasma phosphorylated tau181 (P-tau181) has demonstrated diagnostic accuracy for AD comparable to that of Tau positron emission tomography (Tau PET), a validated diagnostic tool, achieving an area under the curve (AUC) of 0.92–0.96 [92,93].